Covered recipient · General Payments record
SABRINA W CLARK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,607.69
- Reported across 197 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $793.18 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $301.40 | 14 |
| PFIZER INC. | $91.40 | 5 |
| Neurelis, Inc. | $89.91 | 4 |
| Amgen Inc. | $59.97 | 2 |
| SK Life Science, Inc. | $58.71 | 2 |
| EISAI INC. | $49.38 | 2 |
| Nevro Corp. | $43.16 | 2 |
| Sumitomo Pharma America, Inc. | $43.07 | 3 |
| Biogen, Inc. | $38.44 | 2 |
| Marinus Pharmaceuticals, Inc. | $17.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $34.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117416463 | CMS |
| Amgen Inc. | $25.64 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117416465 | CMS |
| Biogen, Inc. | $19.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104815127 | CMS |
| Biogen, Inc. | $19.22 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104824084 | CMS |
| Eisai Inc. | $23.14 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110819701 | CMS |
| Eisai Inc. | $26.24 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110819703 | CMS |
| Marinus Pharmaceuticals, Inc. | $17.74 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141325260 | CMS |
| Neurelis, Inc. | $23.65 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672392 | CMS |
| Neurelis, Inc. | $17.22 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672394 | CMS |
| Neurelis, Inc. | $28.97 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672396 | CMS |
| Neurelis, Inc. | $20.07 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672398 | CMS |
| Nevro Corp. | $24.53 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130767499 | CMS |
| Nevro Corp. | $18.63 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130767493 | CMS |
| PFIZER INC. | $16.93 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131069967 | CMS |
| PFIZER INC. | $13.45 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115282 | CMS |
| PFIZER INC. | $19.38 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131259501 | CMS |
| PFIZER INC. | $17.15 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131462597 | CMS |
| PFIZER INC. | $24.49 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131468156 | CMS |
| SK Life Science, Inc. | $28.77 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154141509 | CMS |
| SK Life Science, Inc. | $29.94 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154141521 | CMS |
| Sumitomo Pharma America, Inc. | $13.75 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149004475 | CMS |
| Sumitomo Pharma America, Inc. | $13.36 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149004477 | CMS |
| Sumitomo Pharma America, Inc. | $15.96 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149004479 | CMS |
| UCB, Inc. | $22.33 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451494 | CMS |
| UCB, Inc. | $15.71 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451499 | CMS |
| UCB, Inc. | $20.93 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451503 | CMS |
| UCB, Inc. | $5.33 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451507 | CMS |
| UCB, Inc. | $19.39 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451512 | CMS |
| UCB, Inc. | $28.51 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451516 | CMS |
| UCB, Inc. | $23.32 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451521 | CMS |
| UCB, Inc. | $34.98 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451525 | CMS |
| UCB, Inc. | $19.26 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451530 | CMS |
| UCB, Inc. | $22.15 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451534 | CMS |
| UCB, Inc. | $24.67 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451538 | CMS |
| UCB, Inc. | $21.30 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451543 | CMS |
| UCB, Inc. | $21.52 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451547 | CMS |
| UCB, Inc. | $22.00 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143451551 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.